Cell transplantation therapies for central nervous system (CNS) deficits such as spinal cord injury (SCI) have been shown to be effective in several animal models. One cell type that has been transplanted is neural precursor cells (NPCs), for which there are several possible sources. We have studied NPCs derived from human embryonic stem cells (hESCs) and human fetal CNS tissue (hfNPCs), cultured as neurospheres, and the expression of pluripotency and neural genes during neural induction and in vitro differentiation. mRNA for the pluripotency markers Nanog, Oct-4, Gdf3, and DNMT3b were downregulated during neural differentiation of hESCs. mRNA for these markers was found in nonpluripotent hfNPC at higher levels compared to hESC-NPCs. However, Oct-4 protein was found in hESC-NPCs after 8 weeks of culture, but not in hfNPCs. Similarly, SSEA-4 and CD326 were only found in hESC-NPCs. NPCs from both sources differentiated as expected to cells with typical features of neurons and astrocytes. The expressions of neuronal markers in hESC-NPCs were affected by the composition of cell culture medium, while this did not affect hfNPCs. Transplantation of hESC-NPC or hfNPC neurospheres into immunodeficient mouse testis or subcutaneous tissue did not result in tumor formation. In contrast, typical teratomas appeared in all animals after transplantation of hESC-NPCs to injured or noninjured spinal cords of immunodeficient rats. Our data show that transplantation to the subcutaneous tissue or the testes of immunodeficient mice is not a reliable method for evaluation of the tumor risk of remaining pluripotent cells in grafts.
INTRODUCTION
damaged axons. Neural precursor cells (NPCs) for transplantation therapies can be derived from embryonic stem cells, embryonic or fetal CNS, or adult CNS tissue, and Central nervous system (CNS) injuries often lead to severe functional deficits with no curative treatment several methods have been developed for neural differentiation and long-term culture of these cells (9, 39) . available. Much effort is spent on developing therapies for CNS injuries using cell replacement strategies (13, Due to their pluripotency and potential to differentiate into any cell type, human embryonic stem cells 31) . Stem cell therapy could be beneficial by 1) replacing damaged or dead cells, 2) reconnecting injured neu-(hESCs) are a unique source for various types of cell therapies, including treatment of CNS insults and neuro-rons, 3) secreting neurotrophic factors to support survival and regeneration of remaining cells, 4) remyelinating degenerative diseases (13, 23, 26) . Human ESCs are usu-178 SUNDBERG ET AL.
ally derived from the inner cell mass of blastocyst stage NPCs, but that this cannot be reliably assessed in standard teratoma tests. embryos. They can be maintained in pluripotent state in culture and differentiated into tissues of all three germ layers (28, 44) . Following established differentiation pro-MATERIALS AND METHODS tocols, hESCs can be differentiated into neuroectoder-Human ESC Cultures mal cells, and into mature neuronal and glial cells Human ESC lines (HS181 passage 65, HS360 pas- (8, 47) . The ability of these neural cells to regenerate sage 12) were derived from the inner cell mass of superdamaged areas of the CNS has been studied intensively. numerary blastocyst-stage embryos at the Karolinska For example, hESC-derived oligodendrocyte precursors Institute, Karolinska University Hospital Huddinge, cells have been shown to remyelinate axons in spinal Sweden. Approval for these procedures was obtained cord injury (SCI) animal model (23). Still, further optifrom the Regional Ethics Vetting Board in Stockholm. mization is needed for controlled differentiation and pu-
The ethics committee of the Hospital District of Pirkanrification of hESC-derived neural cell populations for maa, Finland (Hovatta, R05051 and Skottman, R05116) transplantation purposes (15, 34) .
has given approval to perform research utilizing the A crucial and largely unresolved problem is the nec-hESC lines derived at the Karolinska Institute. Human essary elimination of remaining pluripotent cells, be-ESCs were cultured as previously described (37) . cause even a few pluripotent cells may be sufficient to Briefly, hESCs were cultured on top of mitotically inacgive rise to tumors (16) . Efficient protocols for phenotivated human foreskin fibroblasts (CRL-2429, ATCC, type induction, as well as reliable markers of pluripo-Manassas, CA) in hESC medium containing knockout tency to be used in elimination of undifferentiated Dulbecco's modified Eagle's medium (DMEM) (Gibco hESCs, are needed in order to achieve clinically accept-Invitrogen, Carlsbad, CA), 20% knockout-SR (Gibco Inable methods for safe cell therapy. A number of markers vitrogen), 2 mM GlutaMax (Gibco Invitrogen), 0.1 mM for pluripotent cells such as Nanog, Oct-4, DNMT3b, minimal essential medium nonessential amino acids SSEA-4, Tra1-81, and CD326 (1,3,41) have been sug-(Cambrex Bio Science, Karlskoga, Sweden), 0.1 mM βgested, but their specificity and selectivity need to be mercaptoethanol (Gibco Invitrogen), 50 U/ml penicillin/ further evaluated. streptomycin (Cambrex Bio Science), and 8 ng/ml hu-Human NPCs can also be isolated from the human man basic fibroblast growth factor (bFGF, R&D Sysembryonic or fetal CNS, or the adult CNS, and extems, Minneapolis, MN). Human ESC colonies were panded in vitro for prolonged periods (36, 45) . Although passaged by mechanical splitting at 5-7-day intervals these cells may have more limited differentiation potenand replated on fresh fibroblasts. Karyotypic normality tial compared to hESC-derived neural precursors, they was confirmed after every 25-30 passages. can give rise to neurons, oligodendrocytes, and astrocytes in vitro (33,45). NPCs derived from the human Neural Induction of hESCs in Suspension Culture embryonic and fetal CNS (hfNPCs) have been transplanted in SCI animals (21) . These cells survive for HS181 and HS360 colonies were mechanically dissected and differentiated into neural cells in suspension months after transplantation to injured rat spinal cord, and differentiate into neurons and astrocytes (2). Impor-culture (29,41). The neural differentiation was performed in two different media: neural differentiation medium tantly, whatever the cell type used for future clinical applications, large amounts of cells have to be produced (NDM) and neural stem cell medium (NSM). NDM contained DMEM/F-12 and neurobasal medium (1:1) sup-under Good Manufacturing Practice (GMP) quality standards, which can be accomplished by modifying pre-plemented with 1 × B27, 1 × N2, 2 mM GlutaMax (Gibco Invitrogen), 25 U/ml penicillin/streptomycin viously published protocols (7, 36, 42) . However, the main concern of hESC-derived cells in cell therapy is (Cambrex Bio Science), and 20 ng/ml bFGF. The NSM contained DMEM/F-12 supplemented with 1 × N2, 2 the risk of tumor formation due to remaining pluripotent cells.
mM GlutaMax (Gibco Invitrogen), 0.6% glucose, 25 U/ ml penicillin/streptomycin supplemented (Cambrex Bio Here, we studied the differences between hESC-NPCs and hfNPCs cultured under equivalent conditions. Science) with 20 ng/ml human epithelial growth factor (EGF, R&D Systems), 20 ng/ml bFGF (R&D Systems), We compared the expression of pluripotency, neural and glial markers, and the propensity for tumor formation and 10 ng/ml human ciliary neurotrophic factor (CNTF, R&D Systems). The neurospheres were mechanically after transplantation to immunodeficient animals. Our results show that there are important differences be-split once a week and cultured up to 20 weeks. All cultures were maintained in a humidified atmosphere at tween the two cell types with respect to expression of pluripotency markers, that these differences are associ-37°C and 5% CO 2 . Unless otherwise specified, analyses of hESC-NPCs were carried out in intact neurospheres. ated with the presence of pluripotent cells among hESC-
Fetal Neural Precursor Cells
City, USA) for Nanog. Primers for SYBR Green chemistry were designed specifically for qPCR and ordered Cultures of hfNPCs derived from human first trimesfrom Thermo Electron GmbH (Germany), and primers ter CNS tissue (6-10 weeks of gestation) were estaband probes for Nanog were custom designed by Applied lished as previously described (2,33). The procedure was Biosystems. Primers were designed to span exon-exon approved by the Regional Ethics Vetting Board, Stockboundaries and primer sequence specificity was conholm, Sweden. Briefly, fetal tissue was retrieved from firmed with NCBI BLAST to eliminate the risk of genoclinical first trimester routine abortions with informed mic contamination. Primers were analyzed with PCR; consent by the woman undergoing termination of pregamplified products were run on agarose gels, cut out, nancy. Identified CNS tissue dissected from the spinal and sequenced. qPCR was done using the 7500 Fast cord and forebrain was homogenized with a glass-Teflon Real-Time PCR System (Applied Biosystems) with the homogenizer and cultured at 100,000-200,000 cells/ml following profile: 1 cycle of 95°C for 10 min, 40 cycles in NSM or NDM. The cultures of free-floating neuof alternating 95°C for 15 s, and 60°C for 30 s followed rospheres were passaged every 7-14 days by enzymatby a melting curve analysis for specificity control. ical dissociation with TrypLE Express (Invitrogen) and
Quantification was done using the ∆∆Ct-method as degentle trituration, and fresh medium added twice a week.
scribed previously (27) . Undifferentiated hESCs (line All cultures were maintained in a humidified atmosphere HS181) were used as a reference sample and GAPDH at 37°C and 5% CO 2 . Unless otherwise specified, analyas reference gene. The Ct values were calculated using ses of hfNPCs were carried out in intact neurospheres.
the 7500 Fast System software, version 1.3.1. Data anal-RNA Extraction and cDNA Synthesis ysis was done with Microsoft Excel. Samples were collected from hESC-NPCs and Immunohistochemistry hfNPCs. RNA was extracted using RNeasy Micro kit Neurospheres derived from hESCs and human fetal (Qiagen, Hilden, Germany). A total of 50 ng of RNA CNS tissue were collected at different time points, fixed was used for cDNA synthesis (Sensiscript RT kit, Qiain 4% paraformaldehyde (PFA), treated with 30% sugen) according to the manufacturer's instructions.
crose over night at 4°C, mounted in Tissue-Tek mount-PCR ing medium (Sakura Finetek, Zoeterwoude Netherlands), and frozen on dry ice. The neurospheres were Each PCR reaction contained 1 µl of cDNA, 0.25 cryostat sectioned at a thickness of 5 µm. Tissue sec-µM of forward and reverse primers, 1× Taq-buffer tions were blocked with 1.5% goat/donkey serum in (−MgCl, +KCl) (Fermentas, Leon-Rot, Germany), 2.5 PBS at 30 min in room temperature (RT), and primary mM dNTP (Fermentas), 25 mM MgCl 2 (Fermentas), antibodies were diluted in 0.3% Triton X-100 in PBS dH 2 O, and 0.6 U Taq-DNA-polymerase enzyme (Ferand incubated overnight at 4°C. After rinsing in PBS the mentas). The PCR program included: denaturation in sections were incubated with secondary antibody in 95°C for 3 min followed with 35 cycles of 95°C for 30 0.3% Triton X-100 PBS for 1 h at RT. Primary antibods, 55°C for 30 s, 72°C for 1 min, and final extension ies used were towards β-tubulin type III (1:800, Sigma), for 5 min at 72°C. The following primers were used for BLPB (1:500, Chemicon, Temecula, CA), GFAP (1: a) pluripotent cells: Nanog, Oct-4, DNMT3b, Activin A 500, DAKO), MAP-2 (1:50, Chemicon), nestin (1:200 receptor; b) mesodermal cell lineages: Brachyury, en-Chemicon). Secondary antibodies used were Cy3-conjudodermal cell lineage: alpha-fetoprotein (AFP); c) gated AffiniPure goat anti-mouse IgG (1:2400, Jackson NPCs: Sox2, nestin, Pax-6, Musashi, Mash1, neural Immuno Research Laboratories, Baltimore, MD, USA), cell adhesion molecule (NCAM); d) radial glial cells:
Alexa Fluor 488-conjugated goat anti-mouse IgG, and brain lipid binding protein (BLBP); e) neuronal cells:
Alexa Fluor 488-conjugated goat anti-rabbit IgG (1: Doublecortin, MAP-2, β-tubulin III; f) astrocytes: glial 1200, both from Molecular Probes, Leiden, the Netherfibrillary acidic protein (GFAP); g) oligodendrocytes:
lands formed with hESC-NPCs cultured in NSM and NDM Quantitative RT-PCR (HS360 and HS181), and hfNPCs cultured in NSM (spinal cord: 566sc and 569sc, forebrain: 575for and 558for) Quantitative RT-PCR (qPCR) was performed with FastStart Universal SYBR Green Master Mix (ROX, at time points of 2, 4, 8, 12, and 20 weeks. Samples were evaluated semiquantitatively using the fluores-Roche) for the genes Oct-4, DNMT3b, Gdf3, GAPDH and with a TaqMan assay (Applied Biosystems, Foster cence microscope (Zeiss, Axiophot). 
Flow Cytometry
stained with hematoxylin-eosin (Sigma) for histological analysis. Immunohistochemistry was performed as de-Human ESC-and fetal-derived neurospheres were scribed above. Human cells were detected using human dissociated into single cells with TrypLe Express (Innuclear marker HuNu (1:250, Chemicon) and hESCvitrogen) and labeled with antibodies diluted according NPCs with β-tubulin III (1:800, Sigma). dwell time. The lesioned spinal cords were covered with Unconjugated antibodies were stained with the followone layer of meningeal substitute (Lyoplant, B/Braun ing secondary antibodies: FITC-conjugated goat anti-Aesculap) prior to suture of the wound as previously mouse IgM (Jackson ImmunoResearch Laboratories) described (2). Eight days later the animals were reanaesand Alexa Fluor 488-conjugated goat anti-mouse IgG thetized and 10-12 hESC-derived neurospheres (cul-(Invitrogen). Cells were incubated with primary antibodtured for 8 weeks to allow neural induction) selected by ies for 30 min in the dark on ice and washed once with size to contain a total of approximately 100,000 cells PBS followed by incubation with the appropriate secwere transplanted to the lesion area. Three groups of ondary antibody for 30 min in the dark on ice and injured rats (6 animals/group) were included and transwashed twice with PBS. Flow cytometry was run on a planted with: a) hESC-NPC cultured in NDM (HS360), FACsort flow cytometer (Beckton Dickinson) using the b) hESC-NPC cultured in NSM (HS360), c) hESC-NPC software Cell Quest. Isotype controls were used to detercultured in NDM (HS181). One group of rats with a mine nonspecific staining and gates were set using dilaminectomy but without contusion injury (6 animals/ rectly conjugated isotype controls and/or unconjugated group = sham rats) was injected with hESC-NPC culisotype controls and the corresponding secondary antitured in NDM (HS360). Animals were followed up to bodies as negative control. Human ESC-NPCs and 12 weeks after injury and testing of hind limb motor hfNPCs were cultured in vitro for 8 weeks prior to flow function was performed 1 day before injury and 1, 3, 6, cytometry analysis. For analysis of hfNPCs, cells from 10, and 12 weeks after injury. Hind limb function was five different cases were used and the average presented. assessed using the Basso, Beattie, and Bresnahan (BBB) motor performance scale (4), with 21 as the score for Teratoma Formation Analysis normal hind limb function, and 0 for complete paralysis. To study teratoma formation, 10-12 intact neurosph-Functional testing was performed by an experienced ineres (in total ϳ100,000 cells) derived from hESCs and vestigator blinded to the experimental design. After the human fetal CNS were transplanted into the right testis motor assessment at 12 weeks, the rats were sacrificed, of severe combined immunodeficiency (SCID) mice (n = and perfusion fixed with 400 ml of 4% PFA in phos-10), as previously described (19, 20) . Equivalent subcuphate buffer, pH 7.4. The dissected spinal cords were taneous transplantations of 10-12 neurospheres (ϳ100,000 postfixed in 4% PFA for 90 min and thereafter rinsed cells) in the left groin were also performed in the same and kept in 30% sucrose until they were cut in 10-µm animals. Undifferentiated hESC of the same cell lines sections and processed for histological analysis as de-(100,000 cells/injection) were used as positive controls. scribed above. After the cell injections, the development of tumors in the testes and subcutis in transplanted animals were fol-RESULTS lowed by manual palpation during 12 weeks. Animals
Gene Expression Profiles of hESC-NPCs and hfNPCs were sacrificed by a lethal dose of intravenous barbiturates before transcardiac perfusion with 4% PFA in 0.1 Gene expression analysis revealed that the expression of pluripotency markers Oct-4, Nanog, and DNMT3b M PBS. Testes were dissected out and a 1-cm 2 piece of the skin and superficial layer of underlying skeletal mus-was downregulated already 2 weeks after initiation of neural induction in hESC-NPCs while quite surprisingly cle at the location of the subcutaneous transplantation was cut out, the tissue was postfixed for 4 h in PFA, these markers were found at comparable levels in hfNPCs during the 12 week follow-up time (Fig. 1) . Ex-and then transferred to 10% sucrose for at least 24 h. Sections (10 µm) were cut on a cryostat (Micron) and pression of neural markers sox2, nestin, Pax-6, double- cortin, Musashi, Mash1, β-tubulin III, MAP-2, and constant levels in hfNPCs. In addition, the expression of antiapoptosis marker BIRC5 was detected in varying NCAM increased in hESC-NPCs during differentiation while hfNPCs expressed these markers constantly dur-levels in both cell types (Fig. 1) .
We also compared cells cultured in NSM and NDM ing 2-12 weeks follow-up. The expression levels of the astrocyte marker GFAP increased in hESC-NPCs and with respect to the gene expression levels. hESC-NPCs cultured in NDM expressed neuronal markers MAP-2 forebrain-derived hfNPCs during later time points of culture, while GFAP expression in spinal cord-derived and NCAM, and radial glial marker BLPB, already after 2 weeks of culturing, whereas hESC-NPCs cultured with hfNPCs remained constant from 2 weeks (Fig. 1) . In hESC-NPCs Olig1 was expressed weakly, and Olig2 ex-NSM expressed these markers at lower levels and after longer time in culture. In contrast, hfNPCs expressed all pression varied, while both of them were expressed at of these markers at similar levels regardless of medium using flow cytometry and immunocytochemistry. A small proportion of hESC-NPCs expressed the pluripo-used (NSM vs. NDM).
tency markers SSEA4 and CD326 after 8 weeks of dif-Quantitative RT-PCR Analysis of Pluripotency Genes ferentiation in vitro, while hfNPCs were negative for these proteins. The other early stem/progenitor cell The results of the semiquantitative RT-PCR with pluripotency genes were confirmed using quantitative markers CD133 and CD15 (SSEA1) was found in hfNPCs although at lower frequency than hESC-NPCs cultured PCR. The mRNA levels for Nanog, Oct-4, DNMT3b, and Gdf3 were significantly lower in hESC-NPCs after 2 in NDM. Cells expressing markers for neural stem/progenitor cells, neuronal and glial cells were common weeks of neural induction compared to undifferentiated hESCs, and decreased during further neural differentia-among hESC-NPCs cultured in NDM while less so among hfNPCs and hESC-NPCs cultured in NSM ( Fig.  tion (Fig. 2A) . In hfNPCs the levels of Nanog, DNMT3b, and Gdf3 mRNAs were higher at 2 weeks after the ini-3). The most pronounced difference concerned the neuronal marker PSA-NCAM which occurred on twice as tial derivation, compared to hESC-derived NPCs (Fig.  2B) and fluctuated during the 12 weeks of study. Two many hESC-NPCs as hfNPCs.
Neurospheres were also analyzed with immunohisto-weeks after differentiation, hESC-NPCs cultured with NDM had higher mRNA levels of Nanog and Oct-4 than chemistry. In accordance with flow cytometry (CD326) and PCR (Oct-4) analysis, occasional cells expressing hESC-NPCs cultured at NSM ( Fig. 2A) . In hfNPCs, the mRNA levels of the pluripotency markers did not show these pluripotency markers were found in hESC-NPCs.
No one of these markers could be detected in hfNPCs any consistent differences with respect to the region of origin or cell culture medium used (Fig. 2B ).
( Fig. 4) . Neuronal markers β-tubulin III and MAP2, glial marker GFAP, and radial glia marker BLBP all in-Protein Expression Analysis creased in sectioned neurospheres of hESC-NPCs during the neural differentiation in NDM. The increase in β-According to the mRNA analysis, expression of pluripotency markers was almost completely suppressed in tubulin III did not appear during differentiation in NSM.
In hfNPCs the immunoreactivity for these markers re-hESC-NPCs after 8 weeks of neural differentiation. Protein expression in NPCs at this time point was analyzed mained the same during the study period except for GFAP, which increased in spinal cord-derived hfNPCs, mice. However, again the hESC-NPCs did not give rise to any macroscopical tumor formation after 12 weeks of while a progressive decrease was seen in forebrainderived hfNPCs (data not shown).
in vivo observation, whereas undifferentiated hESC used as positive control did (data not shown). On microscopic hESC-NPC Transplantation to SCID Mice Testis examination, the hESC-NPC testis grafts consisted of and Subcutaneous Tissue homogenous tissue with a histological appearance resembling neuropil. There was no invasive growth into Initially, a pilot experiment was performed in which dissociated hESC-NPCs, derived from HS181 and the seminiferous tubuli. No cartilage, muscle fibers, pigmented cells, fat, or glands, typical of the teratomas HS360, and differentiated for 8 weeks in vitro, were injected into the testis of 8 SCID mice. As these cells found after transplanting undifferentiated hESCs, could be seen in the grafts (Fig. 5B) . hfNPCs transplanted to did not give rise to any macroscopical teratomas, we transplanted hESC-NPC neurospheres grown in NDM SCID mice testes also survived and developed into a tissue with neural appearance (Fig. 5A ). into the lesioned spinal cord of 10 immunodeficient rats. Unexpectedly, the majority of these rats developed tu-To verify that hESC-NPC neurospheres were indeed successfully transplanted to the mice testes, immunohisto-mors, and histological analysis of a few of these animals verified that the tumors were teratomas. chemical evaluation using human-specific antibody (HuNu) was applied to cryosections of the tissue. The For the analysis of pluripotent cells and teratoma formation, we reasoned that the lack of teratomas in the specificity of the HuNu antibody allowed an efficient screening of the serially sectioned testes in fluorescence first testis transplantation experiment may have been due to the injection of dissociated cells, while intact hESC-microscope, with reliable detection also of small groups of human cells. In 9 out of 10 testes, a human graft could be NPC neurospheres were transplanted to the spinal cord, according to the procedures we previously used for identified in the testis parenchyma (Fig. 5c ). Some transplanted cells were positive for both HuNu and β-tubulin hfNPCs. We therefore transplanted intact hESC-NPC neurospheres into the testis and the subcutaneous tissue III, with a neuron-like morphology indicating neuronal maturation of the transplanted hESC-NPCs (Fig. 5d ). of the groin of a total of 10 immunodeficient SCID
hESC-NPC Transplantation to Rat Spinal Cord DISCUSSION
In the present study, we have investigated the differ-In parallel with the testis and subcutis transplantation experiments, we transplanted the same hESC-NPCs as ences between hESC-derived NPCs and fetal CNSderived hfNPCs-two types of cells with potential for neurospheres into sham or injured spinal cords of immunodeficient rats. In sham rats, the median BBB score future clinical use-in terms of neural differentiation, pluripotency, and risk of teratoma formation. Both was 21 up to 10 weeks postsurgery (Fig. 6A ). Experimental groups with an SCI initially had a reduction in hESC-NPCs and hfNPCs were cultured at similar culture conditions and their gene and protein expression the median BBB score from a prelesion score of 21 to 7-12 at 1 week postlesion. The hind limb function were compared. Thereafter, the teratoma formation capacity of NPCs was tested in testis and subcutaneous thereafter improved up to 6 weeks after injury, reaching BBB scores around 15. However, between 6 and 12 tissue of immunodeficient animals. Finally, we performed a long-term safety study of hESC-NPCs a rat weeks postinjury, hind limb function of all rats gradually declined, including the sham-operated rats transplanted SCI model. hESC-NPCs and hfNPCs were cultured for prolonged with hESC-NPCs (Fig. 6A) .
At postmortem analysis, the spinal cords were swol-time (over 12 weeks) in neural differentiation medium (NDM) and neural stem cell medium (NSM) and their len and semitranslucent at the site of the injury, suggestive of tumor masses with extensive cyst formation ( Fig. gene expression profile for pluripotency and neural markers were studied. As expected, we found a rapid 6B). Microscopically, hematoxylin-eosin-stained sections showed the typical appearance of teratomas, domi-downregulation of the pluripotency genes Nanog, Oct-4, DNMT3b, and Gdf3 (25,29,41) in hESC-NPCs com-nated by large cystic cavities surrounded by tissue representing all three germ layers (Fig. 7) . pared to undifferentiated hESCs. Surprisingly, hfNPCs expressed mRNA for Nanog, Oct-4, DNMT3b, and Gdf3 at levels that were even higher than in hESC-NPCs, according to quantitative PCR analysis. To eliminate falsepositive results, primers for the qPCR analyses of Nanog, Oct-4, DNMT3b, and Gdf3 were designed to span two exons to avoid the risk of contamination with genomic DNA. In addition, the primers used were validated with undifferentiated hESCs. In accordance with our results on hfNPCs, Oct-4 is expressed in nonpluripotent NPCs isolated from adult rhesus macaque brain (10) , and Gdf3 has been found in the human cerebral cortex, hippocampus, and cerebellum (17), as well as in other somatic cell types (22). Importantly, in a recent study on dorsal root ganglia-derived neural stem cells, a large number of cells were immunoreactive to Oct-4, as well as to DNMT1 (40) . However, we are not aware of any previous reports on expression of Nanog in nonpluripotent cells. Despite the low mRNA levels in hESC-NPCs, we could also detect low protein expression of pluripotency markers Oct-4, SSEA4, and CD326 in these cells.
Using a slightly different protocol, Kozubenko and collaborators generated neural precursor cells from hESC which they transplanted as dissociated cells to an ischemic brain injury. Interestingly, according to their flow cytometry data at P5 these cells contained between 2% and 5% cells identified as SSEA-4-, TRA-1-60-, and Nanog-immunoreactive cells, although classified as "negative reaction" by the authors. These P5 cells resulted in teratomas in 5/11 animals while P8 cells did not give rise to a single case. This contrasts to the fraction of cells immunoreactive to the three suggested pluripotency markers, which did not change during this time, and for SSEA-4 increased to 16.5% at P10 (25). According to our results, in contrast to hESC-NPCs the hfNPCs did not express detectable levels of these proteins. Thus, it seems that even relatively low expression levels of pluripotency mRNAs results in protein translation in hESC-NPCs but not in hfNPCs. It is possible that mRNA for pluripotency markers such as Oct-4 is not translated into proteins in hfNPCs, due to micro RNAs that posttranscriptionally modulate genes, and pressed these markers already soon after establishment as neurospheres, and this expression remained stable during the 12 weeks of culture. This agrees with a previ-ous study showing that hfNPCs have a more pronounced nounced differences than previously reported. In repeated experiments with hESC-NPCs transplanted as expression of genes such as GAP43 (growth associated protein 43) and NNAT (neuronatin) compared to hESC-small neurospheres, a total of 100,000 cells consistently gave rise to teratomas in the rat spinal cord, while we NPCs (39) . It is important to note, however, that the two cell types studied in this analysis were not cultured un-could not detect a single case of tumor growth after intratesticular or subcutaneous transplantations in mice. der similar conditions, which reduces the accuracy of their comparisons, and also prevents a more conclusive To ensure that there was sufficient time for the teratomas to develop, the transplanted animals were kept for comparison with our data. Here, both NPCs derived from hESCs and human fetal CNS expressed neural 12 weeks. During this time, the hind limb motor function of SCI rats recovered to some extent according to markers at protein level after 8 weeks of culture. As we have described previously, expression of neural proteins the BBB rating, reaching similar levels that are shown in other studies at 6 weeks time point (23). However, in hESC-NPC increases over time (41) , while their expression is relatively constant in hfNPC s during in vitro during the later part of the 12 weeks follow-up time, functional deterioration and extensive growth of terato-culture (33).
When comparing different medium compositions, we mas in spinal cords were seen in 26/26 rats with hESC-NPCs transplants. In contrast, hESC-NPC spheres grafted found that hESC-NPCs cultured in NDM expressed neuronal markers MAP-2 and NCAM, and radial glial marker to testis survived in 9/10 mice and differentiated into neural tissue, with no signs of expansive tumor growth. BLPB, already after 2 weeks of culturing, whereas these markers appeared later and at lower levels in hESC-NPCs By using undifferentiated hESC as positive controls, we confirmed that the procedures used were appropriate, as cultured in NSM. Flow cytometry analysis showed that NDM also promoted expression of neural stem cell/pre-described previously (19) . The survival of transplanted hESC-NPCs was also confirmed. cursor markers CD133, CD15 as well as neuronal markers CD56 and PSA-NCAM. In contrast, hfNPCs ex-We want to emphasize that we do not claim that cells giving rise to intraspinal tumors are unable to develop pressed all of these markers at similar levels regardless of medium used (NSM vs. NDM). Thus, while composi-into tumors in testis or other locations. The hESC-NPCs may develop into teratomas in testis if sufficient num-tion of the medium critically affects the cell fate of hESC-NPCs, the neural commitment of hfNPCs is inde-bers are transplanted. We used no more than 100,000 cells for these grafts, because this is a number of cells pendent of the cell culture medium used. NDM consists of neurobasal medium with B27 supplement, which are that previously have been used in SCI transplantation experiments; 100,000 undifferentiated hESCs were suf-known factors to induce neuronal differentiation (11, 29) , while NSM contains N2 supplement in DMEM/F12, ficient for generating tumors in the positive controls, as has also been shown previously (24) . Intraspinal trans-which are less permissive to neural differentiation (11) . Compared to hESC-NPCs cultured in NDM, hfNPCs ex-plantation of a suspension of 1 million cells or moretypically used in teratoma experiments-is not compati-pressed lower amounts of CD133, CD15, and PSA-NCAM in NSM but higher amounts of CD44. In addi-ble with the small tissue volume of the rat spinal cord. We conclude that with the number of cells used, there tion, when fetal CNS tissue is the source of NPCs, the regional differences between forebrain-and spinal cord-are surprisingly large differences in the permissiveness for tumor formation between the rat spinal cord and derived NPCs can affect the expression levels of neural markers (32,46). Here, the spinal cord-derived NPCs ex-SCID mouse testis and subcutis. A consequence of this finding is that there may be similar differences between pressed astrocyte marker GFAP constantly and at higher levels compared to forebrain-derived NPCs, as shown the human spinal cord and the models commonly used to evaluate tumorigenesis; that is, neural cells derived previously at the protein level (33). Hence, both the medium composition and the origin of the cells are impor-from pluripotent cells may appear as safe in routine teratoma tests and lead to tumor growth after transplantation tant factors to take into account when differentiating NPCs either from hESCs or fetal tissue.
to human SCI patients. Whether the spinal cord is a CNS region uniquely permissive to growth of pluripotent cells Intratesticular injections of cells (38) followed by analysis of teratoma formation are generally considered is to our knowledge not known, because comparisons have only been made between regions of the brain, ex-a reliable assay for identifying the presence of pluripotent cells in cell preparations. Recent studies have shown cluding the spinal cord (14).
There are several examples of protocols for neural that there are differences between target organs with regard to the propensity of transplanted hESC to develop differentiation of hESC that apparently eliminate pluripotent cells (30, 47) and thus the risk of teratoma growth, teratomas (16) , and also between different brain regions (14). In the present study we found even more pro-also after transplantation to the spinal cord (23 transplantations, but these genes are according to our results not specific for pluripotent cells. The number of REFERENCES pluripotent cells in hESC-derived neurospheres was ap- 
